camptothecin has been researched along with Anemia, Fanconi in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Keck, JL; Manthei, KA; Voter, AF | 1 |
Chen, J; Hu, Q; Kim, H; Klages-Mundt, N; Kuma Saha, L; Li, L; Lynn, E; Paull, T; Shen, X; Srivastava, M; Takeda, S; Tian, Y; Wang, R; Ye, Y; Zhang, H | 1 |
Adelman, CA; Borel, V; Boulton, SJ; Matsuzaki, K; Schindler, D | 1 |
Gautier, J; Hoatlin, ME; Stone, S; Wang, LC | 1 |
Agarwal, S; Ali, AM; Andreassen, PR; Bakker, ST; de Winter, JP; Du, CH; Fan, Q; Godthelp, BC; Grassman, E; Jansen, M; Joenje, H; Meetei, AR; Rooimans, MA; Singh, TR; Steltenpool, J; Wahengbam, K; Williams, DA | 1 |
Bettecken, T; de Winter, JP; Eirich, K; Hain, K; Hilhorst-Hofstee, Y; Jaspers, NG; Joenje, H; Korthof, ET; Nieuwint, AW; Oostra, AB; Rooimans, MA; Rouse, J; Schindler, D; Schuster, B; Steltenpool, J; Stoepker, C | 1 |
Auerbach, AD; Kim, Y; Lach, FP; Smogorzewska, A; Spitz, GS; Veturi, U | 1 |
Averbeck, D; Duchaud, E; Moustacchi, E; Rosselli, F | 1 |
Grompe, M; Jakobs, PM; Moses, RE; Neeley, TL; Saito, H | 1 |
Epe, B; Hoehn, H; Poot, M | 1 |
10 other study(ies) available for camptothecin and Anemia, Fanconi
Article | Year |
---|---|
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanconi Anemia; High-Throughput Screening Assays; Humans; Multiprotein Complexes; Protein Interaction Maps; RecQ Helicases | 2016 |
The ARK Assay Is a Sensitive and Versatile Method for the Global Detection of DNA-Protein Crosslinks.
Topics: Camptothecin; Cross-Linking Reagents; DNA; DNA Repair; DNA-Binding Proteins; Etoposide; Fanconi Anemia; Gene Knockout Techniques; Genetic Techniques; HeLa Cells; Humans; Topoisomerase I Inhibitors | 2020 |
FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathway.
Topics: Animals; Antineoplastic Agents; Basic-Leucine Zipper Transcription Factors; Camptothecin; Cell Line; Cells, Cultured; DNA Damage; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Fanconi Anemia Complementation Group Proteins; Female; Fibroblasts; Genetic Predisposition to Disease; Humans; Lymphoma; Male; Mice, Knockout; Microsatellite Instability; Mitomycin; Neoplasms, Glandular and Epithelial; RNA Helicases; Ultraviolet Rays | 2015 |
Fanconi anemia proteins stabilize replication forks.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Aphidicolin; Ataxia Telangiectasia Mutated Proteins; Camptothecin; Cell Cycle Proteins; Cell Nucleus; Cell-Free System; Chromatin; DNA Damage; DNA Repair; DNA Replication; Enzyme Inhibitors; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Fanconi Anemia Complementation Group L Protein; Mitomycin; Phosphorylation; Protein Serine-Threonine Kinases; Xenopus laevis; Xenopus Proteins | 2008 |
Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.
Topics: Adenosine Triphosphatases; Camptothecin; Cell Line, Tumor; Cross-Linking Reagents; DNA Helicases; Drug Resistance; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Fanconi Anemia Complementation Group D2 Protein; Gene Expression; Humans; Mutation; Radiation Tolerance; Recombinant Proteins; Transfection; Ubiquitination; Ultraviolet Rays | 2009 |
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.
Topics: Alleles; Camptothecin; Child; Cross-Linking Reagents; DNA Repair; Dose-Response Relationship, Drug; Fanconi Anemia; Heat-Shock Proteins; HSC70 Heat-Shock Proteins; Humans; Immunoprecipitation; Male; Mitomycin; Mutation; Phenotype; Recombinases | 2011 |
Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4.
Topics: Camptothecin; Cell Line; Cross-Linking Reagents; DNA; DNA Mutational Analysis; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Endodeoxyribonucleases; Endonucleases; Fanconi Anemia; Humans; Mitomycin; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Interaction Mapping; Protein Structure, Tertiary; Recombinant Fusion Proteins; Recombinases; Topoisomerase I Inhibitors | 2013 |
Comparison of the effects of DNA topoisomerase inhibitors on lymphoblasts from normal and Fanconi anemia donors.
Topics: Camptothecin; Cell Division; Cells, Cultured; Chromosome Aberrations; DNA; DNA Damage; DNA Repair; Fanconi Anemia; Hematopoietic Stem Cells; Humans; Indoles; Isoquinolines; Lymphocytes; Methoxsalen; Nalidixic Acid; Novobiocin; Skin; Topoisomerase I Inhibitors | 1994 |
Fanconi anemia cells have a normal gene structure for topoisomerase I.
Topics: Base Sequence; Camptothecin; Cell Line; Cell Survival; Cell Transformation, Viral; Cells, Cultured; DNA; DNA Mutational Analysis; DNA Primers; DNA Topoisomerases, Type I; Fanconi Anemia; Humans; Mitomycin; Molecular Sequence Data; Polymerase Chain Reaction | 1994 |
Cell cycle effects of the DNA topoisomerase inhibitors camptothecin and m-AMSA in lymphoblastoid cell lines from patients with Fanconi anemia.
Topics: Amsacrine; Bromodeoxyuridine; Camptothecin; Cell Line; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Fanconi Anemia; Flow Cytometry; G2 Phase; Humans; Lymphocytes; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1992 |